- Patent Title: Cell penetrating peptides that inhibit IRF5 nuclear localization
-
Application No.: US17472760Application Date: 2021-09-13
-
Publication No.: US11746133B2Publication Date: 2023-09-05
- Inventor: Betsy J. Barnes
- Applicant: Rutgers, The State University of New Jersey
- Applicant Address: US NJ New Brunswick
- Assignee: Rutgers, The State University of New Jersey
- Current Assignee: Rutgers, The State University of New Jersey
- Current Assignee Address: US NJ New Brunswick
- Agency: Amster, Rothstein & Ebenstein LLP
- The original application number of the division: US15758276
- Main IPC: A61K38/08
- IPC: A61K38/08 ; A61K38/16 ; A61K38/00 ; A61P37/02 ; C07K7/06 ; C07K7/08 ; C07K14/47 ; C07K14/00
Abstract:
Inhibitors of interferon regulatory factor 5 (IRF5) nuclear localization and methods of using the inhibitors to treat autoimmune diseases such as systemic lupus erythematosus (SLE) are described.
Public/Granted literature
- US20210403520A1 CELL PENETRATING PEPTIDES THAT INHIBIT IRF5 NUCLEAR LOCALIZATION Public/Granted day:2021-12-30
Information query
IPC分类:
